Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharma OHD ApS
APS
Active
CVR 43088939
Jægersborg Alle 14, 2920
Charlottenlund
Activities of holding companies
·
NACE 6421
Est. 2022 · 4 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
Pharma OHD ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Gross profit
-20
-23
-5
-26
Staff expenses
-0
-0
-0
-0
EBITDA
-20
-23
-5
-26
Depreciation & amort.
-0
-0
-0
-0
EBIT
-20
-23
-5
-26
Net financials
3.819
2.813
1.976
3.955
Profit before tax
3.800
2.791
1.971
3.929
Tax
-66
-118
-96
-59
Net profit
3.866
2.908
2.067
3.988
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
17.627
16.199
15.516
15.161
Equity
3.324
6.232
8.299
12.287
Long-term debt
5.647
5.157
1.571
0
Short-term debt
8.657
4.809
5.646
2.874
Total debt
14.304
9.966
7.217
2.874
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-2576600.0%
This company
2022
2025
Equity ratio
81.0%
This company
38.2%
Market median
+112% vs market
2022
2025
Return on equity
32.5%
This company
18.4%
Market median
+77% vs market
2022
2025
Net profit margin (of gross profit)
398802000.0%
This company
2022
2025
Asset turnover (of gross profit)
-0.00×
This company
2022
2025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-07-01 – 2022-12-31
View
PDF
More on Pharma OHD ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
